866-997-4948(US-Canada Toll Free)

Latuda Analysis and Forecasts from 2011 to 2020

Published By :

GlobalData

Published Date : Jul 2011

Category :

Therapeutic Area

No. of Pages : 32 Pages


GlobalDatas pharmaceuticals report, Latuda Analysis and Forecasts from 2011 to 2020 provides Latuda sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2011-2020). The report also includes information on Schizophrenia market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. 

Scope
  • Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
  • Analysis and review of Latuda including sales data
  • Qualitative and quantitative assessment of market space
  • Analysis of the trends, drivers and restraints shaping and defining the markets
  • In-depth analysis of Latuda including efficacy, safety, pricing, competition and other details which influence its sales potential
  • Detailed sales forecast for 2011-2020 for Latuda in each of the seven major markets
Reasons to buy
  • Understand and capitalize by identifying products that are most likely to ensure a robust return
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drugs performance 
  • Examine the historical sales performance of a drug in seven major markets
  • Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Table of Content

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3

2 Introduction 4
2.1 Schizophrenia 4
2.2 Symptoms 4
2.3 Schizophrenia Market 4
2.4 Epidemiology 4
2.5 Etiology 5
2.5.1 Genetic Factors 5
2.5.2 Environmental Factors 5
2.5.3 Abnormal Brain Structure 6
2.6 GlobalData Report Guidance 6

3 Schizophrenia: Market Characterization 7
3.1 Schizophrenia Market 7
3.2 Schizophrenia Market Forecasts and CAGR 7
3.3 Drivers of Schizophrenia Therapeutics Market 8
3.3.1 Patent Expiry of Leading Marketed Drugs 8
3.3.2 Increasing Patient Pool 8
3.3.3 High Prescription Rates 8
3.3.4 Low Patient Compliance Rate 8
3.3.5 High Unmet Need 8

4 Classification of Schizophrenia 9
4.1 Age of Onset of Schizophrenia 9
4.1.1 Pediatric / Adolescent / Childhood Schizophrenia 9
4.1.2 Adult Schizophrenia 10
4.2 Associated Symptoms 10
4.2.1 Paranoid Schizophrenia 10
4.2.2 Disorganized Schizophrenia 10
4.2.3 Catatonic Schizophrenia 10
4.2.4 Residual Schizophrenia 10
4.2.5 Undifferentiated Disorder 10

5 Treatment for Schizophrenia 11
5.1 Crisis Resolution Teams (CRT) 11
5.2 Voluntary and Compulsory Detention 11
5.3 Antipsychotics 11
5.3.1 Typical Antipsychotics 11
5.3.2 Atypical Antipsychotics 12
5.3.3 Increased Mortality in Elderly Patients with Dementia-Related Psychosis 12

6 Latuda 13
6.1 Introduction 13
6.2 Mechanism of Action 13
6.3 Clinical Studies 13
6.4 Development Status of Latuda 14
6.5 Factors Affecting the Sales of Latuda 15
6.5.1 Better Safety Profile 15
6.5.2 High Competition 15
6.5.3 Market Exclusivity 15
6.5.4 Failure of PanAsia Phase III Trial 15
6.6 Drug Evaluation 15
6.6.1 Drug Risk Benefit Score 15
6.6.2 Intensity of Competition 16
6.7 Sales Forecasts 18
6.7.1 Target Patient Pool of Latuda 18
6.7.2 Dosing 18
6.7.3 Market Penetration 18
6.7.4 Annual Cost of Therapy 18
6.7.5 Sales Estimates of Latuda 20

7 Schizophrenia Market: Appendix 29
7.1 Market Definitions 29
7.2 Abbreviations 29
7.3 Research Methodology 29
7.4 Drug Sales Estimates Model 31
7.5 Contact Us 31
7.6 Disclaimer 32
7.7 Sources 32

List of Table


Table 1: Latuda, Results of Phase III Studies 14
Table 2: Latuda, Results of PEARL Study 14
Table 3: Latuda, Development Status, 2010 14
Table 4: Drug Risk Benefit Score of Latuda 16
Table 5: Competitors of Latuda 17
Table 6: Latuda, Annual Treatment Costs for Schizophrenia 19
Table 7: Latuda, Schizophrenia, Global, Estimated Sales ($m), 20112020 20
Table 8: Latuda, Schizophrenia, The US, Estimated Sales ($m), 20112020 21
Table 9: Latuda, Schizophrenia, UK, Estimated Sales ($m), 20182020 22
Table 10: Latuda, Schizophrenia, France, Estimated Sales ($m), 20182020 23
Table 11: Latuda, Schizophrenia, Germany, Estimated Sales ($m), 20182020 24
Table 12: Latuda, Schizophrenia, Italy, Estimated Sales ($m), 20182020 25
Table 13: Latuda, Schizophrenia, Spain, Estimated Sales ($m), 20182020 26
Table 14: Latuda, Schizophrenia, Japan, Estimated Sales ($m), 20172020 27

List of Chart


Figure 1: Risk of Developing Schizophrenia 5
Figure 2: Environmental Factors in the Development of Schizophrenia 6
Figure 3: Schizophrenia, Global, Market Size Forecasts ($bn), 20102020 7
Figure 4: Classification of Schizophrenia based on the Age of Disease Onset 9
Figure 5: Reduction in PANSS Scores for Atypical Antipsychotics 17
Figure 6: Drug Model Diagram of Latuda 18
Figure 7: Latuda, Schizophrenia, Global, Estimated Sales ($m), 20112020 20
Figure 8: Latuda, Schizophrenia, The US, Estimated Sales ($m), 20112020 21
Figure 9: Latuda, Schizophrenia, UK, Estimated Sales ($m), 20182020 22
Figure 10: Latuda, Schizophrenia, France, Estimated Sales ($m), 20182020 23
Figure 11: Latuda, Schizophrenia, Germany, Estimated Sales ($m), 20182020 24
Figure 12: Latuda, Schizophrenia, Italy, Estimated Sales ($m), 20182020 25
Figure 13: Latuda, Schizophrenia, Spain, Estimated Sales ($m), 20182020 26
Figure 14: Latuda, Schizophrenia, Japan, Estimated Sales ($m), 20172020 27
Figure 15: Latuda, Schizophrenia, Global, Sales Distribution in Major Countries (%), 2020 28

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *